| Christine Davenport, | |
|
361 Hospital Rd Ste 522, Newport Beach, CA 92663-3526 | |
| (949) 645-5918 | |
| Not Available |
| Full Name | Christine Davenport |
|---|---|
| Gender | Female |
| Speciality | Anesthesiologist Assistant |
| Location | 361 Hospital Rd Ste 522, Newport Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063624526 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | PA16399 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Davenport, 361 Hospital Rd Ste 522, Newport Beach, CA 92663-3526 Ph: (949) 645-5918 | Christine Davenport, 361 Hospital Rd Ste 522, Newport Beach, CA 92663-3526 Ph: (949) 645-5918 |
News Archive
Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. Until now.
A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.
Egocentric, self-centred, and insensitive to the needs of others: these social problems often arise in people with severe traumatic brain injury (TBI) and have been attributed in part to a loss of emotional empathy, the capacity to recognise and understand the emotions of other people.
The president will propose cutting spending on Medicare, the federal health program for the elderly, and Medicaid, the joint federal-state program for the poor and disabled. However, he isn't proposing the structural changes that experts say are needed to control spending in these programs over the long term.
Medtronic, Inc. today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient Surgical Technologies, Inc. Both of the companies are focused on advanced energy surgical technologies and will broaden Medtronic Surgical Technologies' portfolio of innovative surgical products to meet customer and patient needs worldwide.
› Verified 4 days ago